New standards for MDMA, psilocybin

Manufactured or compounded psychedelics must be up to scratch to ensure consistency of products supplied to Australian patients, says TGA The Department of Health and Aged Care has published two new quality standards—one for MDMA and another for psilocybin—following a public consultation process with interested stakeholders including pharmacists. From 1 July last year, MDMA and